Express report: pharmaceuticals

Ended Awarded Last action

Contract number
VA24617E6824
Awardee
Awarding agency
Obligated
$76,587

Award facts

Contract value 100% obligated
$76,587.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Deerfield, IL 60015, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 -$6,161
Original award $82,748

About this award

This federal contract award, with ID VA797P14A0003|VA24617E6824, was issued by the Department of Veterans Affairs (VA) to Lundbeck LLC, a global pharmaceutical company. The contract is for the delivery of various pharmaceutical products, including Sabril (vigabatrin) for treatment-resistant seizures, Xenazine (tetrabenazine) for chorea associated with Huntington's disease, and Northera (droxidopa) for neurogenic orthostatic hypotension. The contract, which is not set-aside, has a ceiling value of $76,587.20 and an ultimate completion date of September 1, 2017. Lundbeck holds a five-year Federal Supply Schedule contract for pharmaceuticals and drugs with a potential value of $124 million, under which the VA and other federal agencies can procure Lundbeck's medications. Additionally, Lundbeck holds a $31.5 million Blanket Purchase Agreement with the VA National Acquisition Center, facilitating orders for the aforementioned medications to treat veterans with epilepsy, Huntington's chorea, and orthostatic hypotension.

Quick answers

Who was awarded contract VA24617E6824?

VA24617E6824 was awarded to Lundbeck LLC by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 5, 2017.

How much is contract VA24617E6824 worth?

The government has obligated $76,587 on VA24617E6824.

Is contract VA24617E6824 an order under another contract?

Yes. VA24617E6824 is a BPA call under V797D30249-VA797P14A0003, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA24617E6824 competed?

The extent of competition for VA24617E6824 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award